Description
SPE2D2-25-D-0009 P00001 to exercise Option Year 1 effective April 27, 2026 through April 26, 2027. SPE2D2-25-D-0009 Norgestimate/Ethinyl Estradiol Tablets Award
Award Details
Classification
Place of Performance
Contracting Office
Contacts
Attachments (2)